The collaboration aims to combine synthetic biology with cutting-edge detection technology to create a first-of-its-kind oral pill embedded with tumor-targeting sensors
Alport Syndrome is caused by genetic mutations affecting type IV collagen in the kidneys, ears, and eyes
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
Relmada expects to initiate its Phase 3 program in the first half of 2026
Encouraging early detection and breaking the silence around men’s health
Experts urge early detection & better access to care
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
Pflow is a revolutionary, disposable, and portable home based urine flow measurement test
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Subscribe To Our Newsletter & Stay Updated
